Search
Anika Therapeutics Inc
ANIKAdd to Watchlist
14.550USD
-4.780-24.73%
Close 11-06 16:00（ET）
194.68MMarket Cap
LossP/E TTM
Today
-24.73%
5 Days
-30.55%
1 Month
-24.34%
6 Months
-1.49%
Year to Date
+51.40%
1 Year
+47.72%
Key Figures
17.870Open
17.880High
17.31KVolume
LossP/E TTM
46.41P/E Dynamic
--Dividend TTM
0.13%Turnover Ratio
19.330Prev. Close
13.900Low
262.01KTurnover
LossP/E Static
1.41P/B
0.00%Div Yield TTM
-5.99%ROA
22.88052wk High
0.19Volume Ratio
-56.38MNet Profit
13.38MShares
-0.7916EPS TTM
0.22Beta
-7.85%ROE
9.01052wk Low
34.35%Amplitude
63.65%Gross Margin
194.68MMarket Cap
14.65Reward/Risk
3.57%Risk Rate
Anika Therapeutics Inc's Score
0.32vs previous score
Forecast9.00
Financial Health7.98
Technical5.05
Valuation Dimensions7.81
Institutional Confidence10.00
Risk Assessment6.02
Media Coverage
Coverage Level
Very Low
Very High
Neutral
Analyst Rating
Anika Therapeutics Inc Technical Analysis
Technical Indicators
Strong sell
Summary
Sell
Moving Average
Strong sell
Anika Therapeutics Inc Latest Earnings Call Transcripts
Anika (ANIK) Q3 2026 Earnings Call: Revenue Up 10%, 2026 Outlook Raised
Anika Q3 2026 revenue rose 10% to $30.6 million, gross margin reached 62%, and management raised its revenue and adjusted EBITDA margin outlook.
Financial Indicators
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
Earnings
Next reporting date
--
Reporting Period
2026Q3
Earnings / Forecast
-0.02/0.06
Revenue / Forecast
30.59M/29.44M
Anika Therapeutics Inc Profile
SectorHealthcare Equipment & Supplies
Ticker SymbolANIK
Number of employees288
CountryUnited States of America
Ownership
| Shareholders | Proportion |
|---|---|
| Caligan Partners, LP | 10.79% |
| BlackRock Institutional Trust Company, N.A. | 6.87% |
| BlackRock Financial Management, Inc. | 5.23% |
| Acadian Asset Management LLC | 4.56% |
| Shareholder Types | Proportion |
|---|---|
| Investment Advisor | 33.00% |
| Investment Advisor/Hedge Fund | 29.66% |
| Hedge Fund | 25.32% |
| Research Firm | 7.36% |
Related Instruments
-0.40%
+2.63%
-3.23%
+1.73%
-3.36%
-2.90%
-2.75%
+3.10%
-2.46%
-1.48%
-2.62%
-1.80%
-4.23%
+1.31%
-0.78%
+0.79%
-0.30%
+5.33%
+1.73%
-2.05%Popular Instruments
51828.500
+537.900 (+1.05%)
27146.400
+181.900 (+0.68%)
7430.700
+50.700 (+0.69%)
12797.000
-1.000 (-0.01%)
59050.000
+908.000 (+1.56%)
6251.200
+110.600 (+1.80%)
87.032
-2.825 (-3.14%)
342.370
-1.800 (-0.52%)
186.640
+5.040 (+2.78%)
4129.180
+63.510 (+1.56%)
FAQs
What is the current price of Anika Therapeutics Inc (ANIK)?
The current price of Anika Therapeutics Inc (ANIK) is 14.55.
What is the symbol of Anika Therapeutics Inc?
The ticker symbol of Anika Therapeutics Inc is ANIK.
What is the 52-week high of Anika Therapeutics Inc?
The 52-week high of Anika Therapeutics Inc is 22.88.
What is the 52-week low of Anika Therapeutics Inc?
The 52-week low of Anika Therapeutics Inc is 9.01.
What is the market capitalization of Anika Therapeutics Inc?
The market capitalization of Anika Therapeutics Inc is 194.68M.
Is Anika Therapeutics Inc (ANIK) currently rated as Buy, Hold, or Sell?
According to analysts, Anika Therapeutics Inc (ANIK) has an overall rating of STRONG BUY, with a price target of 23.00.
What is the Earnings Per Share (EPS TTM) of Anika Therapeutics Inc (ANIK)?
The Earnings Per Share (EPS TTM) of Anika Therapeutics Inc (ANIK) is -0.79.